This inventor holds 44 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Composition. Top assignees: Glenmark Pharmaceuticals S.a., Glenmark Specialty S.a., Ichnos Sciences Sa. Active years: 2010-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pachpakhadi, IN (2013)
- Thane (W), IN (2018)
- Maharashtra, IN (2012 - 2023)
- Thane, IN (2010 - 2024)
Company Filing History:
33 out of 65 
9 out of 26 
2 out of 13 Years Active: 2010-2025
Areas of Expertise:
Title: Neelima Khairatkar-Joshi: Innovator in Pharmaceutical Science
Introduction
Neelima Khairatkar-Joshi, located in Thane, India, is a prominent inventor with an impressive portfolio of 43 patents. She has made significant contributions to the field of pharmaceuticals, particularly in developing treatments for allergic rhinitis. Her innovative approaches are paving the way for improved therapeutic options.
Latest Patents
One of Neelima's latest patents is focused on the treatment of allergic rhinitis using a combination of mometasone and olopatadine. This invention provides a method for treating allergic rhinitis in subjects, such as pediatric patients, through the nasal administration of an effective amount of a fixed-dose pharmaceutical composition. This composition comprises mometasone or its salts and olopatadine or its salts.
Another noteworthy patent is a nasal dispensing device that includes a container and a dispenser head equipped with a pump, dispensing channel, and orifice. This device is designed to deliver a pharmaceutical composition containing mometasone and olopatadine effectively. The innovative design features a conically shaped internal bottom and an angled deepened well, ensuring efficient delivery of the medication.
Career Highlights
Throughout her career, Neelima has demonstrated her expertise while working at reputable companies such as Glenmark Pharmaceuticals and Glenmark Specialty. Her tenure at these organizations has allowed her to focus on the development of novel pharmaceutical compositions, enhancing treatment options for patients suffering from allergic conditions.
Collaborations
Neelima has collaborated with several notable professionals in her field, including Abraham Thomas and Vidya Ganapati Kattige. These collaborations have fostered innovation and contributed to the successful development of her patented inventions.
Conclusion
In conclusion, Neelima Khairatkar-Joshi's contributions to pharmaceutical innovation are invaluable. Her extensive patent portfolio and collaborative efforts position her as a leading inventor in the treatment of allergic rhinitis, ultimately benefiting countless patients in need of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile